Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(18%)
Results Posted
17%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
3
27%
Ph phase_4
4
36%
Ph not_applicable
3
27%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
4(40.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
Recruiting2
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (30.0%)
Phase 44 (40.0%)
N/A3 (30.0%)

Trials by Status

recruiting218%
completed655%
unknown218%
terminated19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11